Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Novavax Stock Could Skyrocket in December

TheMotleyFool

0 0

Don't forget about Novavax (NASDAQ: NVAX). It could be easy for investors to do so. The company's COVID-19 vaccine still isn't authorized in any major market. Its shares are more than 30% below the high set early this year and remain 20% lower than where they traded just three months ago.

But I think the chances are very good that Novavax is poised to soon take off. Here's why Novavax stock could skyrocket in December.

Image source: Getty Images.

Source Fool.com

Like: 0

NVAX

Share